Today: 27 April 2026
Browse Category

SWX:ROG.SW 18 November 2025 - 20 December 2025

Healthcare Stocks News Today: Drug Pricing Shake-Up, Biotech M&A, IPO Momentum, and 2026 Outlook (Dec. 20, 2025)

Healthcare Stocks News Today: Drug Pricing Shake-Up, Biotech M&A, IPO Momentum, and 2026 Outlook (Dec. 20, 2025)

President Donald Trump and nine major drugmakers announced deals to cut U.S. drug prices for Medicaid and cash-paying patients, with discounts up to 70% off list prices and a three-year tariff reprieve. Shares of several companies rose modestly after the news. Commitments include free Eliquis for Medicaid and steep discounts on diabetes and migraine drugs. The moves reshape investor expectations for healthcare stocks heading into 2026.
20 December 2025
········
MSCI Europe vs World Indices: Performance, Forecasts and Key Drivers (5–7 December 2025)

MSCI Europe vs World Indices: Performance, Forecasts and Key Drivers (5–7 December 2025)

The MSCI Europe Index closed at 2,564.76 on Dec. 5, down 0.25% after a recent rally, but remains up about 12.5% to 15.5% year-to-date in 2025. The index outpaces the MSCI World, which is up roughly 7.7% for the year. European stocks continue to trade at lower valuations, with a 3.03% dividend yield and forward P/E of 14.64. The MSCI Europe Index has 402 constituents and a market cap near $12.85 trillion.
7 December 2025
···········
Swiss Stock Market Today, 26 November 2025: SMI Edges Higher as Sentiment Surges and Insurers Face Tougher Rules

Swiss Stock Market Today, 26 November 2025: SMI Edges Higher as Sentiment Surges and Insurers Face Tougher Rules

The Swiss Market Index closed up 0.07% at 12,781.09 on Wednesday, its highest in about a week, extending a three-day advance. Turnover topped 2.4 million contracts. Investor sentiment jumped after a thaw in Swiss-US trade tensions. Zurich Insurance, Swiss Re, and Swiss Life drew attention after being added to the G20 Financial Stability Board’s insurer resolution list.
26 November 2025
········
Olema Pharmaceuticals (OLMA) Soars Over 200% After Roche Breast Cancer Trial Win — What It Means for Palazestrant and Investors on November 18, 2025

Olema Pharmaceuticals (OLMA) Soars Over 200% After Roche Breast Cancer Trial Win — What It Means for Palazestrant and Investors on November 18, 2025

Olema Pharmaceuticals shares surged as much as 220% in pre-market trading on November 18 after Roche announced a Phase 3 win for its oral SERD giredestrant in early-stage breast cancer. The spike was driven by investor read-through to Olema’s similar drug palazestrant, not new Olema data. Volume hit 13.4 million shares, far above average. Shares later retreated toward the low-$20s during regular trading.
18 November 2025
·····
Swiss Stock Market Today, November 18, 2025: SMI Slips as Roche Soars, ABB, Zurich and ams-Osram Drag the Index

Swiss Stock Market Today, November 18, 2025: SMI Slips as Roche Soars, ABB, Zurich and ams-Osram Drag the Index

The Swiss Market Index fell 0.7% to 12,505 by late morning on November 18, 2025, as global equity declines hit financials and industrials. Roche jumped over 6% to a multi-month high after announcing positive phase III results for its breast cancer drug. ABB, Zurich Insurance, and ams-Osram dropped following investor updates and earnings news. Broader European indices also traded sharply lower.
18 November 2025
····

Stock Market Today

  • Daily Dividend Updates: Portland General Electric, Stanley Black & Decker, Armstrong World, Woodward, Badger Meter
    April 27, 2026, 1:05 PM EDT. On April 24, 2026, Portland General Electric (PGE) raised its quarterly dividend by 5% to $0.55125 per share, payable July 15 to shareholders as of June 25. PGE aims for a long-term payout ratio between 60% and 70%. Stanley Black & Decker declared a Q2 dividend of $0.83 per share, payable June 23 to owners on record June 8. Armstrong World Industries announced a $0.339 dividend payable May 26 to shareholders of record May 11. Woodward set a $0.32 dividend for the quarter, payable June 4 to holders as of May 21. Badger Meter declared a $0.40 quarterly dividend, payable June 5 to shareholders on record May 22. These dividends reflect steady payout policies across diverse sectors.

Latest article

Rocket Lab Stock Slips as SpaceX IPO Hype Meets a Hard Earnings Test

Rocket Lab Stock Slips as SpaceX IPO Hype Meets a Hard Earnings Test

27 April 2026
Rocket Lab shares fell 2.3% to $77.83 Monday, extending recent volatility as investors await first-quarter results due May 7. A technical note flagged weak near-term sentiment despite strong annual revenue growth and a $1.85 billion backlog. SpaceX’s planned IPO has increased scrutiny of space-sector valuations. Rocket Lab completed its second dedicated launch for JAXA on April 23.
RTX Stock Just Got Downgraded After an 11% Slide. The Earnings Beat Wasn’t Enough

RTX Stock Just Got Downgraded After an 11% Slide. The Earnings Beat Wasn’t Enough

27 April 2026
RTX traded near $174 Monday after Erste Group downgraded the stock to “hold” from “buy,” following an 11% drop over five sessions despite strong quarterly results and a raised 2026 outlook. The company reported Q1 sales of $22.1 billion, up 9%, and adjusted EPS of $1.78, up 21%. Tariff costs and valuation concerns continued to weigh on shares. RTX’s market value stands near $235 billion.
Bill Ackman’s Uber Bet Just Got a $10 Billion Robotaxi Test

Bill Ackman’s Uber Bet Just Got a $10 Billion Robotaxi Test

27 April 2026
Uber shares rose about 2% Monday, trading near $76.17, after renewed focus on Bill Ackman’s stake and autonomous vehicle plans. Uber and Lucid agreed to buy at least 25,000 Lucid vehicles for robotaxi use, raising Uber’s total Lucid commitment to 35,000 units. An Uber subsidiary will purchase $200 million in Lucid stock. Competition from Waymo, Tesla, and Chinese rivals is intensifying.
Go toTop